7 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Article Searches
Green smoothies, the hearty drink with a health halo https://www.nrn.com/consumer-trends/green-smoothies-hearty-drink-health-halo Apr 04, 2024 - Green smoothies can vary widely in ingredients, but the core component is usually a leafy green vegetable. It’s usually spinach or kale, but it could also include the fleshy leaves of the aloe vera plant or other nutrient-dense greens. Those are puré
Halozyme Therapeutics (HALO) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates https://www.zacks.com/stock/news/2270054/halozyme-therapeutics-halo-q1-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2270054 May 07, 2024 - The headline numbers for Halozyme Therapeutics (HALO) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick https://www.zacks.com/stock/news/2274099/are-you-a-value-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2274099 May 15, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Compared to Estimates, Halozyme Therapeutics (HALO) Q4 Earnings: A Look at Key Metrics https://www.zacks.com/stock/news/2228804/compared-to-estimates-halozyme-therapeutics-halo-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2228804 Feb 20, 2024 - The headline numbers for Halozyme Therapeutics (HALO) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Fate Therapeutics (FATE) Down 8% Since Last Earnings Report: Can It Rebound? https://www.zacks.com/stock/news/2246796/fate-therapeutics-fate-down-8-since-last-earnings-report-can-it-rebound?cid=CS-ZC-FT-realtime_blog-2246796 Mar 27, 2024 - Fate Therapeutics (FATE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick https://www.zacks.com/stock/news/2251176/are-you-a-growth-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2251176 Apr 05, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Halozyme Therapeutics (HALO) Q1 Earnings Beat Estimates https://www.zacks.com/stock/news/2269973/halozyme-therapeutics-halo-q1-earnings-beat-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2269973 May 07, 2024 - Halozyme Therapeutics (HALO) delivered earnings and revenue surprises of 14.49% and 2.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Pages: 1

Page 1